Positron Emission Tomography News and Research

RSS

Novelos initiates enrollment in HOT Phase 1b trial for advanced solid tumors

Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for treatment and diagnosis of cancer, today announced that it has enrolled the first patient in a U.S. multi-center Phase 1b dose-escalation trial of its cancer-targeted molecular radiotherapeutic compound (131)I-CLR1404 (HOT) in cancer patients with advanced solid tumors.

18 Jan 2012

Drinking alcohol leads to release of endorphins in the brain

Drinking alcohol leads to the release of endorphins in areas of the brain that produce feelings of pleasure and reward, according to a study led by researchers at the Ernest Gallo Clinic and Research Center at the University of California, San Francisco.

12 Jan 2012

FDG-PET safe and accurate in detecting dementia, Alzheimer's

In a new review of imaging studies spanning more than ten years, scientists find that a method of positron emission tomography (PET) safely and accurately detects dementia, including the most common and devastating form among the elderly, Alzheimer's disease.

7 Jan 2012

FLT-PET imaging can effectively detect mantle cell lymphoma

Positron emission tomography (PET) and a molecular imaging agent that captures the proliferation of cancer cells could prove to be a valuable method for imaging a form of Non-Hodgkin's disease called mantle cell lymphoma, a relatively rare and devastating blood cancer.

22 Dec 2011

Decision support tool for objective diagnostics of Alzheimer's

European PredictAD project, lead by Principal Scientist Jyrki Lötjönen from VTT Technical Research Centre of Finland, has developed a decision support tool for objective diagnostics of Alzheimer's disease.

15 Dec 2011

Health Canada approves Positron's Attrius system

Positron Corporation, a leading molecular imaging company specializing in the field of nuclear cardiology is pleased to announce today that on December 12, 2011, the Company's Positron Emission Tomography Scanner(s) Attrius & Attrius L have received approval for sale in Canada.

15 Dec 2011

PET scans can provide insight into process that causes aortic stenosis

Patients with life-threatening heart valve disease could be helped with alternative scanning techniques that provide greater insight into the condition.

13 Dec 2011

HCI earns NCI's Center for Quantitative Imaging Excellence certification

Precise, accurate imaging—think mammography, CT and MRI scans—is important to cancer screening, treatment, and follow-up care. Now, even more advanced technology is emerging, and with it, the need for imaging specialists with the expertise to use them.

9 Dec 2011

Ecstasy drug associated with chronic changes in human brain

Recreational use of Ecstasy - the illegal "rave" drug that produces feelings of euphoria and emotional warmth - is associated with chronic changes in the human brain, Vanderbilt University investigators have discovered.

8 Dec 2011

Phillips gets FDA approval for its combo PET/MRI scanner

Royal Philips Electronics NV has received approval from U.S. regulators to introduce a single medical imaging device that can scan the body for cancer using two technologies.

29 Nov 2011

Blood stem cells engineered to create cancer-killing T-cells

Researchers from UCLA's cancer and stem cell centers have demonstrated for the first time that blood stem cells can be engineered to create cancer-killing T-cells that seek out and attack a human melanoma. The researchers believe this approach could be useful in 40 percent of Caucasians with this malignancy.

29 Nov 2011

Multi-center cabozantinib trial for hormone receptor-positive breast cancer with bone metastases initiated

Exelixis, Inc. today announced the initiation of an investigator-sponsored trial of cabozantinib in women with hormone receptor-positive breast cancer with bone metastases.

21 Nov 2011

Higher protein load in critical brain regions linked to severe depression in late life

Depression is one of the most common mental disorders in the elderly, but little is known about the underlying biology of its development in older adults.

8 Nov 2011

Chemical breakthrough could simplify drug development process

A new chemical process developed by a team of Harvard researchers greatly increases the utility of Positron Emission Tomography (PET) in creating real-time 3-D images of chemical process occurring inside the human body.

5 Nov 2011

Deficits in endocannabinoid function may contribute to eating disorders

A new report in Biological Psychiatry suggests that deficits in endocannabinoid function may contribute to anorexia nervosa and bulimia.

1 Nov 2011

NCI awards ImaginAb $2.3M grant to develop PET diagnostic imaging agents

ImaginAb, Inc. is pleased to announce that it has been awarded a total of $2.3 million in funding from the National Cancer Institute's Small Business Innovation Research program to help further develop diagnostic imaging agents for Positron Emission Tomography.

1 Nov 2011

C-11 choline PET/CT scans can be utilized as prostate cancer staging tool

Recent studies have suggested that C-11 choline positron emission tomography/computerized tomography (PET/CT) scans can be utilized as a staging and potentially therapeutic tool in prostate cancer.

22 Oct 2011

Two Philadelphia scientists to receive John Scott Award

Two internationally recognized scientists with strong Philadelphia ties are to receive the John Scott Award this year.

21 Oct 2011

Brain scans can evaluate new treatments for attention deficit disorder

Scientists have developed a way to evaluate new treatments for some forms of attention deficit disorder. Working in mice, researchers at Washington University School of Medicine in St. Louis showed that they can use brain scans to quickly test whether drugs increase levels of a brain chemical known as dopamine.

15 Oct 2011

AiC: Health Research receives U.S. Army grant for neuroimaging studies of human performance

The Arlington Innovation Center: Health Research (AiC: Health Research), of Virginia Tech's National Capital Region, has been awarded a $1.5 million cooperative research and development agreement from the U.S. Army for neuroimaging studies of human performance.

14 Oct 2011